Volv Global and Sanofi present new research at ISPOR 2026 on Pompe Disease: Real-World Endpoint Mapping and Identification of Evolving Phenotypes of Pompe Disease using Machine Learning
Tech Tour Growth Health is one of Europe's most established gatherings at the intersection of…
Volv Global is pleased to be participating in the Life Sciences Innovation & Investment Corridor…
The idea that an AI system could detect a disease that appears nowhere in a…
The ISPOR International Annual Conference 2026 brings together global leaders in health economics and outcomes…
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Inflammatory Bowel Disease (IBD) management has…
Introduction Advocacy plays a critical role in accelerating progress in rare diseases. As technology advances,…